News | May 28, 2025
Fluor-built Bayer cell therapy facility in California achieves LEED v4 platinum certification
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Campaign empowers women to prioritise their health through thought provoking films, influencer-led campaigns, scientific and medical podcasts, survivor experiences, and digital awareness
Akums invested Rs. 272 crore in capital expenditure during FY25
YESINTEK is indicated for the treatment of adults and children from the age of 6 years and olde
The company recorded its quarterly consolidated revenue from operations at Rs. 61.22 crore in Q4 FY25
For the full year FY25, net profit soared 12x to Rs 345 crore
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Subscribe To Our Newsletter & Stay Updated
